Yeah you are correct, sorry about that.
TLX591-CDx is under standard review with FDA. The mid cycle review meeting date is 16th Feb 2021 and label review date of 30th May 2021. I am not sure how different the time line is with Lantheus where the action date would be 28th May. TLX has applications in EU, Canada and Australia, as well as other products in the pipeline.
https://hotcopper.com.au/threads/ann-fda-new-drug-application-for-tlx591-cdx-proceeds-to-review.5806346/
Competition, page-15
-
- There are more pages in this discussion • 240 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.65 |
Change
0.250(1.36%) |
Mkt cap ! $6.233B | |||
| Open | High | Low | Value | Volume |
| $18.56 | $18.81 | $18.43 | $49.28M | 2.643M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4262 | $18.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.68 | 1840 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| TLX (ASX) Chart |